The Recall Desk

State

Delaware product recalls

73,570 recalls have nationwide distribution and so reach Delaware. 3,438 additional recalls listed Delaware specifically in their distribution scope.

What the numbers show

Total
3,438
Critical
477
Severe
1,110
Most recent
2026-10-14

Of the 3,438 recalls naming Delaware we have scored against our rubric, 477 (14%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 1,110 (32%) are Severe.

These figures cover only the 3,438 recalls whose distribution notice names Delaware specifically. The 73,570 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.

27101–27125 of 77008

  • SevereNHTSA·21V138000·2021-03-04

    2020-2021 Nissan Altima tie rod fastener defect may cause steering loss

    Nissan is recalling certain 2020-2021 Altima vehicles because the tie rod ball joint fastener was not tightened properly. This could cause the fastener to detach and result in loss of steering control.

    Product
    NISSAN — NISSAN ALTIMA
    Category
    Vehicle
    Distribution
    Distributed nationwide
  • SevereNHTSA·21V134000·2021-03-04

    Ferrara Recalls 2019-2020 Inferno Vehicles for Steering Gear Bolt Issue

    Ferrara Fire Apparatus is recalling 2019-2020 Inferno vehicles because steering gear mounting bolts may loosen, causing steering difficulties and increased crash risk.

    Product
    FERRARA — FERRARA INFERNO
    Category
    Vehicle
    Distribution
    Distributed nationwide
  • SevereNHTSA·21V137000·2021-03-04

    KIA Sportage and Cadenza electrical short circuit poses engine fire risk

    Certain 2017-2021 Sportage and 2017-2019 Cadenza vehicles have a defective hydraulic control unit that may short-circuit and ignite an engine compartment fire. Owners should park outside until repairs are completed.

    Product
    KIA — KIA SPORTAGE, CADENZA
    Category
    Vehicle
    Distribution
    Distributed nationwide
  • HighCPSC·21724·2021-03-04

    Polaris Recalls Ranger and ProXD Vehicles Due to Throttle Crash Hazard

    Polaris is recalling approximately 15,800 Ranger and ProXD off-road vehicles because the throttle pedal may stick or return slowly, creating a crash risk.

    Product
    Model Year 2020-2021 RANGER 1000, RANGER CREW 1000, RANGER XP 1000, and RANGER CREW XP 1000 and Model Year 2020 ProXD 2000G, ProXD 2000G H, ProXD 4000G, and ProXD 4000G H
    Category
    Vehicle
    Distribution
    Distributed nationwide
  • HighNHTSA·21V139000·2021-03-04

    Nissan Recalls Infiniti FX35 and FX45 Vehicles for Air Bag Defect

    Nissan is recalling specific Infiniti FX35 and FX45 vehicles because a previously replaced front passenger air bag cushion was folded incorrectly, which could tear during deployment.

    Product
    INFINITI — INFINITI FX35, FX45
    Category
    Vehicle
    Distribution
    Distributed nationwide
  • HighCPSC·21725·2021-03-04

    Casa Kids Recalls Cabina Bunk Beds for Fall Hazard

    Casa Kids is recalling Cabina Bunk Beds because loose screws can cause the mattress foundation to fall, posing a risk to children.

    Product
    Cabina Bunk Beds
    Category
    Consumer Product
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-0286-2021·2021-03-03

    Cisatracurium Besylate Injection Recalled Due to Labeling Error

    Meitheal Pharmaceuticals is recalling 34,860 vials of Cisatracurium Besylate Injection because cartons were mislabeled as Phenylephrine Hydrochloride.

    Product
    CISATRACURIUM BESYLATE — CISATRACURIUM BESYLATE (CISATRACURIUM BESYLATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-0269-2021·2021-03-03

    NDAL Recalls ManukaGuard Nasal Spray Due to Yeast Contamination

    NDAL Mfg Inc. is recalling ManukaGuard Medical Grade Manuka Honey Allercleanse Nasal Spray because the product was confirmed to contain yeast.

    Product
    ManukaGuard Medical Grade Manuka Honey Allercleanse Nasal Spray, 1.3 FL OZ (40mL) bottle, 270 measured sprays, Distributed by Ndal Laboratories, 449 Alvarado St., Monterey, CA 93940 (bottle); NDAL MFG Inc., 80 Garden Court, Suite 100, Monterey, CA 93940 (carton); UPC 8 58631…
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0281-2021·2021-03-03

    Teva Recalls MethyIPREDNISolone Acetate Injectable Suspension Due to Sterility Concerns

    Teva Pharmaceuticals is recalling specific lots of MethyIPREDNISolone Acetate Injectable Suspension because manufacturing areas exceeded microbial acceptance levels, compromising sterility assurance.

    Product
    MethyIPREDNISolone Acetate Injectable Suspension USP, 80 mg/mL, 1 mL Single-Dose Vial (NDC 0703-0051-01), packaged in 25X1ML vials per tray (NDC 0703-0051-04), Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0283-2021·2021-03-03

    Teva Recalls MethyIPREDNISolone Acetate Injectable Suspension Due to Sterility Concerns

    Teva Pharmaceuticals is recalling 6,710 vials of MethyIPREDNISolone Acetate Injectable Suspension because manufacturing areas exceeded microbial acceptance levels, compromising sterility assurance.

    Product
    MethyIPREDNISolone Acetate Injectable Suspension USP, 200 mg/5 mL (0 mg/mL), 5 mL Multiple-Dose Vial, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0703-0043-01.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0277-2021·2021-03-03

    Teva Recalls Metoclopramide Injection Due to Sterility Concerns

    Teva Pharmaceuticals is recalling Metoclopramide Injection because manufacturing areas exceeded microbial acceptance levels, creating a lack of sterility assurance.

    Product
    METOCLOPRAMIDE — METOCLOPRAMIDE (METOCLOPRAMIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0272-2021·2021-03-03

    Teva Recalls Desmopressin Acetate Injection Due to Sterility Concerns

    Teva Pharmaceuticals is recalling Desmopressin Acetate Injection because manufacturing areas exceeded microbial limits, compromising sterility assurance.

    Product
    Desmopressin Acetate Injection USP, 4 mcg/mL, 1 mL Preserved Vial (NDC 0703-5051-01), packaged in 10X1 mL Vials per Tray (NDC 0703-5051-03), Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0276-2021·2021-03-03

    Teva Recalls Leucovorin Calcium Injection Due to Sterility Concerns

    Teva Pharmaceuticals is recalling Leucovorin Calcium for Injection because manufacturing areas exceeded microbial recovery levels, compromising sterility assurance.

    Product
    Leucovorin Calcium for Injection, USP, 100 mg/vial, Single-Dose Vial, Rx only, Teva Parenteral Medicines, Inc., Irvine, CA 92618, NDC 0703-5140-01.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereNHTSA·21V131000·2021-03-03

    Porsche Recalls Macan Models Due to Front Passenger Air Bag Sensor Defect

    Porsche is recalling certain 2015-2018 Macan models because the front passenger seat occupancy sensor may fail to detect a passenger, preventing the air bag from deploying.

    Product
    PORSCHE — PORSCHE MACAN S, MACAN TURBO, MACAN, MACAN GTS
    Category
    Vehicle
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0275-2021·2021-03-03

    Teva Recalls MethyIPREDNISolone Acetate Injectable Suspension Due to Sterility Concerns

    Teva Pharmaceuticals is recalling specific lots of MethyIPREDNISolone Acetate Injectable Suspension because manufacturing areas exceeded microbial acceptance levels, compromising sterility assurance.

    Product
    MethyIPREDNISolone Acetate Injectable Suspension USP, 40 mg/mL, 1 mL Single-Dose Vial (NDC 0703-0031-01), packaged in 25X1ML per tray (NDC 0703-0031-04), Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0279-2021·2021-03-03

    Teva Recalls Vecuronium Bromide Injection Due to Sterility Concerns

    Teva Pharmaceuticals is recalling specific lots of Vecuronium Bromide for Injection because manufacturing areas exceeded microbial acceptance levels, compromising sterility assurance.

    Product
    Vecuronium Bromide for Injection, 10 mg, 1 mg/mL when reconstituted to 10 mL, 10 mL Vial (NDC 0703-2914-01), packaged in 10 x 10 mL Vials per tray (NDC 0703-2914-03), Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0285-2021·2021-03-03

    Teva Recalls Leucovorin Calcium Injection Due to Sterility Concerns

    Teva Pharmaceuticals is recalling Leucovorin Calcium for Injection because manufacturing areas exceeded microbial acceptance levels, compromising sterility assurance.

    Product
    Leucovorin Calcium for Injection, USP, 350 mg/vial, Rx only, labeled as a) Teva Parenteral Medicines, Inc., Irvine, CA 92618, and b) Manufactured By: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, novaplus+, NDC 0703-5145-01.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0284-2021·2021-03-03

    Teva Recalls MethyIPREDNISolone Acetate Injectable Suspension Due to Sterility Concerns

    Teva Pharmaceuticals is recalling 15,043 vials of MethyIPREDNISolone Acetate Injectable Suspension because manufacturing areas exceeded microbial acceptance levels, compromising sterility assurance.

    Product
    MethyIPREDNISolone Acetate Injectable Suspension USP, 400 mg/5 mL (80 mg/mL), 5 mL Multiple-Dose Vial, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0703-0063-01.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0274-2021·2021-03-03

    Teva Recalls Epoprostenol Sodium Injection Due to Sterility Concerns

    Teva Pharmaceuticals is recalling Epoprostenol Sodium for Injection because manufacturing areas exceeded microbial acceptance levels, compromising sterility assurance.

    Product
    Epoprostenol Sodium for Injection, 0.5 mg/vial (500,000 ng), 1X10ML vial, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0703-1985-01.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0273-2021·2021-03-03

    Teva Recalls Sterile Diluent for Epoprostenol Sodium Due to Sterility Concerns

    Teva Pharmaceuticals is recalling specific lots of Sterile Diluent for Epoprostenol Sodium for Injection because manufacturing areas exceeded microbial acceptance levels, compromising sterility assurance.

    Product
    Sterile Diluent for Epoprostenol Sodium for Injection, 50 mL vial (NDC 0703-9258-01), packaged in 2X50ML per tray (NDC 0703-9258-09), Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0278-2021·2021-03-03

    Teva Recalls Toposar Etoposide Injection Due to Sterility Assurance Issues

    Teva Pharmaceuticals is recalling Toposar (etoposide) injection vials because manufacturing areas exceeded microbial acceptance levels, compromising sterility assurance.

    Product
    Toposar (etoposide injection USP), 1 gram/50 mL (20 mg/mL), 50 mL Multiple-dose Vial, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0703-5657-01.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0282-2021·2021-03-03

    Teva Recalls MethyIPREDNISolone Acetate Injectable Suspension Due to Sterility Concerns

    Teva Pharmaceuticals is recalling specific lots of MethyIPREDNISolone Acetate Injectable Suspension because manufacturing areas exceeded microbial acceptance levels, compromising sterility assurance.

    Product
    MethyIPREDNISolone Acetate Injectable Suspension USP, 400 mg/10 mL (40 mg/mL), 10 mL Multiple-Dose Vial, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0703-0045-01.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0280-2021·2021-03-03

    Teva Recalls Epoprostenol Sodium Injection Due to Sterility Concerns

    Teva Pharmaceuticals is recalling Epoprostenol Sodium for Injection because manufacturing areas exceeded microbial acceptance levels, compromising sterility assurance.

    Product
    Epoprostenol Sodium for Injection, 1.5 mg/vial (1,500,000 ng), 10 mL vial, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0703-1995-01.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0271-2021·2021-03-03

    Teva Recalls Dacarbazine Injection Due to Sterility Assurance Concerns

    Teva Pharmaceuticals is recalling Dacarbazine for Injection USP because manufacturing areas exceeded microbial recovery levels, compromising sterility assurance.

    Product
    Dacarbazine for Injection USP, 200 mg, Single Use Vial (NDC 0703-5075-01), packaged in 10X20 ML Single Use Vials per tray (NDC 0703-5075-03); Rx only, TEVA Pharmaceuticals USA, INC., North Wales, PA 19454.
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighCPSC·21090·2021-03-03

    Haro Recalls Masi Bicycles Due to Fork Steerer Tube Breakage Hazard

    Haro Bicycles is recalling approximately 510 Masi Evoluzione and Gran Corsa bicycles from model years 2017-2020 because the fork steerer tube can break, causing riders to lose control and fall.

    Product
    Model Year 2017-2020 Masi Evoluzione and Gran Corsa bicycles
    Category
    Consumer Product
    Distribution
    Distributed nationwide